These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6414198)

  • 1. [Immunoprophylaxis and immunotherapy of infection caused by Pseudomonas aeruginosa: research results and prospects].
    Stanislavskiĭ ES; Joó I
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Jul; (7):22-31. PubMed ID: 6414198
    [No Abstract]   [Full Text] [Related]  

  • 2. Antigens of Pseudomonas aeruginosa and their use in immunoprophylaxis and immunotherapy.
    Stanislavsky ES; Dmitriev BA; Lányi B; Joó I
    Acta Microbiol Hung; 1985; 32(1):3-37. PubMed ID: 2412389
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunoprophylaxis and immunotherapy of experimental Pseudomonas aeruginosa sepsis].
    Grishina IA; Terekhova RP; Marchuk AI
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Apr; (4):14-7. PubMed ID: 3087118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunoprophylaxis and immunotherapy of Pseudomonas infections in burns with polyvalent Pseudomonas aeruginosa corpuscular vaccine.
    Ionescu A; Meitert E; Vasiliu S; Meitert T; Milicescu S; Sima F; Savulian C
    Arch Roum Pathol Exp Microbiol; 1979; 38(3-4):317-30. PubMed ID: 122594
    [No Abstract]   [Full Text] [Related]  

  • 5. Vaccines against Pseudomonas aeruginosa results and perspectives of investigations (survey).
    Joó I; Stanislavskii ES
    J Hyg Epidemiol Microbiol Immunol; 1982; 26(4):417-27. PubMed ID: 6819316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas aeruginosa antigens as potential vaccines.
    Stanislavsky ES; Lam JS
    FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemical components of pathogens and the mechanism of their virulence: Pseudomonas aeruginosa vaccine].
    Homma Y; Tanimoto H
    Nihon Rinsho; 1986 Sep; 44(9):2016-21. PubMed ID: 3099035
    [No Abstract]   [Full Text] [Related]  

  • 8. The efficiency of specific immunization with corpuscular vaccines in the treatment and prophylaxis of Pseudomonas aeruginosa infections of the bones.
    Denischi A; Meitert E; Cursaru A; Purghel E; Stăngulescu D; Sima F; Savulian C; Chersulick E; Petrescu AM; Costin M
    Arch Roum Pathol Exp Microbiol; 1987; 46(2):111-27. PubMed ID: 3138966
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cell-free Pseudomonas vaccine. IV. Laboratory trials of the effectiveness of experimental Pseudomonas vaccines].
    Stanislavskiĭ ES; Joó I; Bulk VF; Zhvanetskaia MI; Mashilova GM
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Oct; (10):25-9. PubMed ID: 6817559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomonas vaccination and immunotherapy: an overview.
    Holder IA
    J Burn Care Rehabil; 2001; 22(5):311-20. PubMed ID: 11570530
    [No Abstract]   [Full Text] [Related]  

  • 11. [Derivation and experimental evaluation of polyvalent corpuscular vaccine for prevention of infections caused by Pseudomonas aeruginosa. I. Development of polyvalent corpuscular vaccine].
    Moroz AF; Radkevich SA; Antsiferova NG; Brodinova NS
    Zh Mikrobiol Epidemiol Immunobiol; 1981; (8):44-9. PubMed ID: 6171956
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of somatic component of Pseudomonas aeruginosa on protective immunity in experimental mouse burn infection.
    Okada K; Kawaharajo K; Kasai T; Homma JY
    Jpn J Exp Med; 1980 Feb; 50(1):53-61. PubMed ID: 6770131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of the protective properties of native and sorbed Pseudomonas aeruginosa anatoxins].
    Dziuban NF
    Mikrobiol Zh (1978); 1983; 45(6):85-7. PubMed ID: 6443863
    [No Abstract]   [Full Text] [Related]  

  • 14. Motility, virulence, and protection with a flagella vaccine against Pseudomonas aeruginosa infection.
    Montie TC; Drake D; Sellin H; Slater O; Edmonds S
    Antibiot Chemother (1971); 1987; 39():233-48. PubMed ID: 3118785
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunotherapy with monovalent Pseudomonas aeruginosa vaccine in chronic respiratory infections.
    Popescu C; Meitert E; Rusu R; Meitert T; Sima F; Savulian C
    Arch Roum Pathol Exp Microbiol; 1982; 41(3):265-76. PubMed ID: 6818929
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of immunotherapy for infections due to Pseudomonas aeruginosa.
    Fisher MW
    J Infect Dis; 1974 Nov; 130 Suppl(0):S149-51. PubMed ID: 4138585
    [No Abstract]   [Full Text] [Related]  

  • 17. [Problems of the immunoprophylaxis of experimental Pseudomonas pyocyanea wound sepsis].
    Kolker II; Stanislavskiĭ ES; Grishina IA
    Zh Mikrobiol Epidemiol Immunobiol; 1979 May; (5):67-72. PubMed ID: 110018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active and passive immunization strategies for Pseudomonas aeruginosa pneumonia.
    Pennington JE; Pier GB; Sadoff JC; Small GJ
    Rev Infect Dis; 1986; 8 Suppl 4():S426-33. PubMed ID: 2944209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pseudomonas aeruginosa preparations for active immunization].
    Nazarchuk LV
    Vrach Delo; 1991 Jul; (7):22-7. PubMed ID: 1771827
    [No Abstract]   [Full Text] [Related]  

  • 20. A polyvalent Pseudomonas vaccine.
    Sato H; Diena BB
    Rev Can Biol; 1974 Jun; 33(2):93-7. PubMed ID: 4211759
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.